Ipsen Public Policy Activities - Global
Ipsen Public Policy Activities
Loading...
  • Media  arrow_down
    < Back
    • Press Releases
    • Media Statements
    • Media Library

    • Our 2023 Integrated Annual Report is live!

       Featured Image
  • Investorsarrow_down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports and Accounts
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Shareholder Information
    • Share-Price Data
    • Regulated Information
    • Key Contacts
  • Partnering
  • Careersarrow_down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Loading...
  • English  EN     Français  FR     EN  arrow_down
    • EnglishEN
    • FrançaisFR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
  • Home
  • Companyarrow_down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Sciencearrow_down
      < Back
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
    • Lay Summaries
  • Sustainabilityarrow_down
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patientsarrow_down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
Back

Post navigation

Previous
Next

Ipsen Public Policy Activities

Ipsen Public Policy Activities

- 12 July 2024 - 0 mins read

Post navigation

Previous
Next

Share this on social media

  • Share on LinkedIn
  • Share on Twitter
  • Share on Facebook

Related Documents

  • Ipsen Public Policy Activities   Download  (76 KB)

Related ESG Documents

Ipsen Sustainable Procurement Ambition
24 September 2024 0 mins read

Ipsen Sustainable Procurement Ambition
Group EHS Policy Commitment
16 September 2024 0 mins read

Group EHS Policy Commitment
Modern Slavery Statement
04 September 2024 0 mins read

Modern Slavery Statement
Advancing EHS and Procurement: Ipsen’s Path to a Sustainable 2030
22 July 2024 0 mins read

Advancing EHS and Procurement: Ipsen’s Path to a Sustainable 2030
2023 HR KPIs – A glimpse on our workplace and workforce
12 July 2024 0 mins read

2023 HR KPIs – A glimpse on our workplace and workforce
ISO 50001 – Signes site
12 July 2024 0 mins read

ISO 50001 – Signes site
ISO 50001 : 2018 – Dreux site
12 July 2024 0 mins read

ISO 50001 : 2018 – Dreux site
Ipsen Human Rights Statement
09 July 2024 0 mins read

Ipsen Human Rights Statement
Ipsen’s Stance on Corruption
09 July 2024 0 mins read

Ipsen’s Stance on Corruption
ISO37001 Anti-Corruption Standard
09 July 2024 0 mins read

ISO37001 Anti-Corruption Standard

IPN price

€108.60

 €-0.50 (-0.46%)

  • Media
  • Investors
  • Partnering
  • Careers
  • Company
  • Sustainability
  • Patients
  • Stories
  • Annual Report
  • Contact us
Latest_Ipsen logo
LinkedIn Twitter Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2024

You are now leaving the Ipsen group website. To continue, please click on Continue?